Michel Baudry is currently Professor of Biomedical Sciences and Dean of the Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, Calif, USA. He was a Professor of Biological Sciences, Neurology, and Biomedical Engineering in the College of Letters, Arts, and Sciences at the University of Southern California, Los Angeles, Calif, USA. After graduating from the prestigious Ecole Polytechnique in Paris (France) in 1971, Baudry obtained a Ph.D. degree in biochemistry at University of Paris VII, Paris, France, in 1977, under the direction of Prof. J.C. Schwartz and Prof. J.P. Changeux, two of the most distinguished French neurobiologists. In 1978, he moved to USA for a postdoctoral period with Prof. Gary Lynch at the University of California, Irvine, Calif, USA. He remained at UCI as an Assistant and then an Associate Professor until 1989, before moving to USC in 1989 and to Western University in 2012. In collaboration with Prof. Lynch, Baudry developed a biochemical theory for learning and memory that is still one of the most widely accepted theories in the field. Baudry?s research is directed at understanding the molecular mechanisms of learning and memory as well as those involved in neurodegenerative processes underlying numerous human brain diseases. Baudry is a world-known neuroscientist and has published over 350 manuscripts in peer-reviewed journals. He is one of the 100 most cited neuroscientists, according to the ISI database. Baudry has also been involved in several biopharmaceutical start-up companies. In 1986 he was one of the cofounders of Synaptics, Inc, the human Interface company, specializing in touchscreen technology. In 1991, he cofounded Eukarion, Inc, with Bernard Malfroy, and more recently participated in the transformation of Eukarion into MindSet, Rx. In 2007, he also cofounded Rhenovia Pharma, a drug discovery and development company located in Mulhouse, France.
Biography Updated on 3 December 2012